Vitamin D, bone, and HIV infection

Area of Science:

• Endocrinology
• Infectious Diseases
• Public Health

Background:

• Vitamin D deficiency is linked to various health issues, including falls, fractures, diabetes, obesity, cardiovascular disease, malignancies, and tuberculosis.
• While observational studies suggest benefits of higher vitamin D levels, randomized trial data are generally limited, except for fall and fracture prevention in the elderly.
• HIV-infected individuals exhibit a high prevalence of vitamin D deficiency, potentially exacerbated by antiretroviral drug interactions with vitamin D metabolism.

Purpose of the Study:

• To review the association between vitamin D deficiency and various health conditions.
• To discuss the current evidence for vitamin D supplementation benefits, particularly in the context of HIV infection.
• To provide recommendations for screening and supplementation strategies in at-risk populations, including HIV-infected individuals.

Main Methods:

• Summary of a presentation at a continuing medical education program.
• Review of existing observational data and randomized trial findings regarding vitamin D.
• Discussion of vitamin D metabolism and its interaction with antiretroviral therapies.

Main Results:

• Vitamin D deficiency is associated with increased risks for falls, fractures, chronic diseases, and infections.
• Evidence supporting vitamin D supplementation benefits is generally lacking from randomized trials, with notable exceptions in elderly fall prevention.
• Limited clinical trial data exist on the specific benefits of vitamin D screening and supplementation in the HIV-infected population.

Conclusions:

• A rational approach involves screening at-risk patients for vitamin D deficiency, including those over 50 or with osteoporosis, prior fractures, or high fall risk.
• Vitamin D supplementation may be considered for specific subgroups of patients.
• Further clinical trial data are needed to fully elucidate the benefits of vitamin D screening and supplementation in the HIV-infected population.